Correlation Between Molecular Partners and Maravai Lifesciences
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Maravai Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Maravai Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Maravai Lifesciences Holdings, you can compare the effects of market volatilities on Molecular Partners and Maravai Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Maravai Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Maravai Lifesciences.
Diversification Opportunities for Molecular Partners and Maravai Lifesciences
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Maravai is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Maravai Lifesciences Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maravai Lifesciences and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Maravai Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maravai Lifesciences has no effect on the direction of Molecular Partners i.e., Molecular Partners and Maravai Lifesciences go up and down completely randomly.
Pair Corralation between Molecular Partners and Maravai Lifesciences
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.07 times more return on investment than Maravai Lifesciences. However, Molecular Partners is 1.07 times more volatile than Maravai Lifesciences Holdings. It trades about 0.02 of its potential returns per unit of risk. Maravai Lifesciences Holdings is currently generating about -0.01 per unit of risk. If you would invest 650.00 in Molecular Partners AG on September 19, 2024 and sell it today you would lose (125.00) from holding Molecular Partners AG or give up 19.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Partners AG vs. Maravai Lifesciences Holdings
Performance |
| Timeline |
| Molecular Partners |
| Maravai Lifesciences |
Molecular Partners and Maravai Lifesciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Maravai Lifesciences
The main advantage of trading using opposite Molecular Partners and Maravai Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Maravai Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maravai Lifesciences will offset losses from the drop in Maravai Lifesciences' long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Maravai Lifesciences vs. Molecular Partners AG | Maravai Lifesciences vs. MediciNova | Maravai Lifesciences vs. Anebulo Pharmaceuticals | Maravai Lifesciences vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |